Medical and Science
MAPA President unpacks the shifting narrative in Medical Affairs and the pressing challenge of corporate reputation

In this Health Industry Hub interview, Lauren Pasfield, President of Medical Affairs Professionals of Australasia (MAPA), deep dived into the shifting narrative in medical affairs, the pressing issue of corporate reputation, and a glimpse into the upcoming MAPA Summit.
One of the most intriguing shifts in the medical affairs function, Pasfield explained, is the delicate balance between commercial imperatives and medical goals – a narrative that was once viewed with scepticism but is now being more openly embraced.
Pasfield attributes this change in mindset to the increasing complexity of the pharma sector including a “necessity out of the success of medical affairs, but also for the business”.
“We’re not OK sitting with the status quo anymore,” she added. “There is this evolving landscape of ‘how do we measure the success of medical affairs teams?“
During the vodcast, Pasfield delved into the pressing issue of corporate reputation, commenting on a report that highlighted while 90% of leaders are deeply concerned about reputational risks, fewer than 40% feel equipped to manage these challenges.
Pasfield discussed how medical affairs can play a crucial role in bridging this preparedness gap through “transparency and trust”, focusing on the most relevant areas for reputation management including scientific integrity.
Looking ahead, Pasfield shared her excitement for the upcoming MAPA Summit on 30-31 October, discussing the theme and why it is particularly timely for the industry. She offered a glimpse into the topics that attendees can expect to explore, emphasising the relevance and importance of each in the current medical affairs environment.
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - MedTech & Diagnostics

Healthcare sector’s political donations: What to expect ahead of the federal election
Ahead of the upcoming federal election, attention turns to the financial contributions to major political parties. The Australian Electoral Commission’s […]
MoreNews & Trends - Pharmaceuticals

‘Underinvestment in gynae cancer has left critical gaps,’ says ANZGOG Chair
Ovarian cancer is the deadliest women’s cancer, with the latest statistics revealing a five-year survival rate of just 49%. Alarmingly, […]
MoreNews & Trends - MedTech & Diagnostics

Labor’s one-off funding a band aid for public hospitals while private sector left in limbo
The Federal Government has committed a one-off funding boost of $1.7 billion to public hospitals under a one-year extension to […]
MoreNews & Trends - Pharmaceuticals

AI-powered test to reshape use of hormone therapy in prostate cancer
Australian researchers are pioneering the use of artificial intelligence (AI) to enhance decision-making in prostate cancer treatment, specifically focusing on […]
More